The association between MMP2 −1306 C > T (rs243865) polymorphism and risk of prostate cancer
Irish Journal of Medical Science, ISSN: 1863-4362, Vol: 186, Issue: 1, Page: 103-111
2017
- 11Citations
- 12Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations11
- Citation Indexes11
- 11
- CrossRef1
- Captures12
- Readers12
- 12
Article Description
Background: Prostate cancer is the second most common cancer in men. Matrix metalloproteinase-2 (MMP2) is the most important member of the matrix metalloproteinase family. MMP2 digests the basement membrane and causes changes in the extracellular matrix which in turn facilitate cancer invasion. It, therefore, has a major role in tumor angiogenesis. Previous studies have identified a single-nucleotide polymorphism C/T at position −1306 of MMP2 gene promoter which is a key regulatory factor in cancer progression. Aim: The present study aimed to determine the association between MMP2 polymorphism and the risk of prostate cancer in Iranian men. Methods: This case–control study was performed on 50 paraffin-embedded prostate cancer tissue samples and 54 blood samples from healthy men. Genotyping of the samples was performed using high-resolution melting analysis (HRM). Finally, 20 % of the genotypes were confirmed by sequencing. Results: No significant associations were found between CT and TT genotypes and the risk of prostate cancer. However, there were no significant relationships between the genotypes and the studied factors, e.g., age, pathological stage, and Gleason Score. Conclusion: MMP2 −1306 C > T (rs243865) polymorphism was not significantly related with prostate cancer susceptibility in Iranian men.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84982315608&origin=inward; http://dx.doi.org/10.1007/s11845-016-1492-9; http://www.ncbi.nlm.nih.gov/pubmed/27541146; http://link.springer.com/10.1007/s11845-016-1492-9; https://dx.doi.org/10.1007/s11845-016-1492-9; https://link.springer.com/article/10.1007/s11845-016-1492-9
Springer Nature
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know